Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 12, 2024

BUY
$1.26 - $1.79 $533,862 - $758,423
423,700 Added 131.87%
745,000 $1.26 Million
Q3 2022

Oct 14, 2022

BUY
$0.73 - $3.74 $234,549 - $1.2 Million
321,300 New
321,300 $1 Million

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $12.1B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Tb Alternative Assets Ltd. Portfolio

Follow Tb Alternative Assets Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tb Alternative Assets Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Tb Alternative Assets Ltd. with notifications on news.